Balstilimab
Balstilimab (AGEN2034) is a fully human monoclonal IgG4 antibody against PD-1[1].
Product Specifications
CAS Number
2148321-77-9
Product Name Alternative
AGEN2034
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/balstilimab.html
Purity
99.51
Solubility
H2O
Smiles
[Balstilimab]
Molecular Weight
(143.33 kDa)
References & Citations
[1]Drouin E E, et al. AGEN1884, an IgG1 anti-CTLA-4 antibody, combines effectively with PD-1 blockade in primary human T cell assays and in a non-human primate pharmacodynamic (PD) model. Cancer Research, 2017, 77 (13_Supplement) : 3654-3654.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
